Andreas von Knethen

12PUBLICATIONS
33CO-AUTHORS
Molecular targetsMechanobiologyRespiratory diseasesPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 08, 2024
Hemojuvelin-mediated hepcidin induction requires both bone morphogenetic protein type I receptors ALK2 and ALK3.

Deniz Y Dogan, Eugen I Urzica, Isabelle Hornung

|Dec 20, 2022
Cross-talk between red blood cells and plasma influences blood flow and omics phenotypes in severe COVID-19.

Steffen M Recktenwald, Greta Simionato, Marcelle G M Lopes

|Apr 15, 2022
Phosphatidylserine Synthase PTDSS1 Shapes the Tumor Lipidome to Maintain Tumor-Promoting Inflammation.

Divya Sekar, Christina Dillmann, Evelyn Sirait-Fischer

|Jan 21, 2022
Antioxidants as Therapeutic Agents in Acute Respiratory Distress Syndrome (ARDS) Treatment-From Mice to Men.

Andreas von Knethen, Ulrike Heinicke, Volker Laux

|Dec 22, 2020
Nrf2-A Molecular Target for Sepsis Patients in Critical Care.

Sandra Gunne, Ulrike Heinicke, Michael J Parnham

Pageof 2